首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Incidence and Virulence Determinants of Verocytotoxin-Producing Escherichia coli Infections in the Brussels-Capital Region Belgium in 2008–2010
【2h】

Incidence and Virulence Determinants of Verocytotoxin-Producing Escherichia coli Infections in the Brussels-Capital Region Belgium in 2008–2010

机译:2008-2010年比利时布鲁塞尔首都大区产产产生细胞毒素的大肠埃希菌感染的发病率和毒力决定因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The incidence of verocytotoxin-producing Escherichia coli (VTEC) was investigated by PCR in all human stools from Universitair Ziekenhuis Brussel (UZB) and in selected stools from six other hospital laboratories in the Brussels-Capital Region, Belgium, collected between April 2008 and October 2010. The stools selected to be included in this study were those from patients with hemolytic-uremic syndrome (HUS), patients with a history of bloody diarrhea, patients linked to clusters of diarrhea, children up to the age of 6 years, and stools containing macroscopic blood. Verocytotoxin genes (vtx) were detected significantly more frequently in stools from patients with the selected conditions (2.04%) than in unselected stools from UZB (1.20%) (P = 0.001). VTEC was detected most frequently in patients with HUS (35.3%), a history of bloody diarrhea (5.15%), or stools containing macroscopic blood (1.85%). Stools from patients up to the age of 17 years were significantly more frequently vtx positive than those from adult patients between the ages of 18 and 65 years (P = 0.022). Although stools from patients older than 65 years were also more frequently positive for vtx than those from patients between 18 and 65 years, this trend was not significant. VTEC was isolated from 140 (67.9%) vtx-positive stools. One sample yielded two different serotypes; thus, 141 isolates could be characterized. Sixty different O:H serotypes harboring 85 different virulence profiles were identified. Serotypes O157:H7/H− (n = 34), O26:H11/H− (n = 21), O63:H6 (n = 8), O111:H8/H− (n = 7), and O146:H21/H− (n = 6) accounted for 53.9% of isolates. All O157 isolates carried vtx2, eae, and a complete O island 122 (COI-122); 15 also carried vtx1. Non-O157 isolates (n = 107), however, accounted for the bulk (75.9%) of isolates. Fifty-nine (55.1%) isolates were positive for vtx1, 36 (33.6%) were positive for vtx2, and 12 (11.2%) carried both vtx1 and vtx2. Pulsed-field gel electrophoresis revealed wide genetic diversity; however, small clusters of O157, O26, and O63:H6 VTEC that could have been part of unidentified outbreaks were identified. Antimicrobial resistance was observed in 63 (44.7%) isolates, and 34 (24.1%) showed multidrug resistance. Our data show that VTEC infections were not limited to patients with HUS or bloody diarrhea. Clinical laboratories should, therefore, screen all stools for O157 and non-O157 VTEC using selective media and a method for detecting verocytotoxins or vtx genes.
机译:通过PCR对2008年4月至10月间收集的Universitair Ziekenhuis Brussel(UZB)的所有人类粪便以及比利时布鲁塞尔首都大区其他六个医院实验室的精选粪便中的PCR产生了产葡萄毒素的大肠杆菌(VTEC)的发生率进行了调查。 2010年。被选为研究对象的粪便是溶血性尿毒症综合征(HUS)患者,有血性腹泻病史,与腹泻有关的患者,6岁以下儿童和粪便。含有肉眼可见的血液。在患有特定疾病的患者的粪便中,检测到Verox毒素基因(vtx)的频率(2.04%)显着高于未选择的UZB粪便(1.20%)(P = 0.001)。在HUS(35.3%),有血性腹泻病史(5.15%)或含有大量血液的粪便中(1.85%),检测到VTEC的频率最高。年龄在17岁以下的患者的凳子vtx阳性的频率明显高于18岁至65岁之间的成年患者的凳子(p = 0.022)。尽管65岁以上患者的粪便vtx阳性率也比18至65岁患者的粪便更为频繁,但这种趋势并不明显。从140个(67.9%)vtx阳性粪便中分离出VTEC。一个样品产生两种不同的血清型。因此,可以鉴定出141个分离株。鉴定出60种不同的O:H血清型,它们具有85种不同的毒力特征。血清型O157:H7 / H-(n = 34),O26:H11 / H-(n = 21),O63:H6(n = 8),O111:H8 / H-(n = 7)和O146:H21 / H-(n = 6)占分离株的53.9%。所有O157分离株均携带vtx2,eae和完整的O岛122(COI-122); 15日还携带了vtx1。但是,非O157分离株(n = 107)占分离株的大部分(75.9%)。 vtx1 有59(55.1%)阳性, vtx2 有36(33.6%)阳性,以及12(11.2%)都带有 vtx1 < / em>和 vtx2 。脉冲场凝胶电泳显示出广泛的遗传多样性。但是,确定了O157,O26和O63:H6 VTEC的小簇,这些簇可能是未确定的暴发的一部分。在63(44.7%)个分离物中观察到了抗菌药耐药性,其中34(24.1%)表现出了多药耐药性。我们的数据表明,VTEC感染不仅限于HUS或血性腹泻患者。因此,临床实验室应使用选择性培养基和检测病毒毒素或 vtx 基因的方法对所有粪便中的O157和非O157 VTEC进行筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号